Clinical trials: Telomere Biology Disorder

Telomere Biology Disorders With Bone Marrow Failure

Rollover Study From EXG-US-01

• Enrolling by invitation
• Age: 18 years and older
• Phase 1
• Injection or infusion

This is a long-term rollover follow-up study for Phase I/II study (Protocol EXG-US-01).

Trial name

NCT05868499

Testing

EXG34217

Where

United States

Volunteers

12 people

Sponsor

Elixirgen Therapeutics, Inc.